Bionime Corporation (4737.TW) TAI

73.00

-0.9(-1.22%)

Updated at August 19 11:33AM

Currency In TWD

Valuation

Market Cap3.94B
Enterprise Value6.79B
P/E Ratio-32.82
PEG Ratio5.3
Price/Sales Ratio2.32
Price/Book Ratio2.35
Enterprise/Revenue3.78
Enterprise/EBITDA116.49

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.07
Operating Margin-0.08

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.07

Income Statement

Revenue1.93B
Revenue/Share32.53
Gross Profit768.38M
EBITDA59.29M
Net Income-127.22M
Diluted EPS-2.1

Balance Sheet

Total Cash382.59M
Total Cash/Share6.39
Total Debt3.17B
Total Debt/Equity1.68
Current Ratio0.77
Book Value Per Share31.57

Price History

52-Week Change14.57
52-Week High80.5
52-Week Low47.45
Moving Average 50 Days74.82
Moving Average 200 Days66.97

Statistics

Average Volume110,960
Shares Outstanding61.09M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.91
Last Split Factor127:125
Last Split DateNovember 20, 2014